Abstract
Background: The pathogenesis of autoantibody generation in anti-factor H (FH) antibody associated atypical hemolytic uremic syndrome (aHUS) is unknown and is perhaps triggered by an infectious or environmental agent. We observed an unusual increase of patients with anti-FH antibody associated aHUS coinciding with the second pandemic wave in New Delhi and suspected that SARS-CoV-2 infection might be a potential trigger.
Methods: We screened for SARS-CoV-2 infection using reverse transcriptase polymerase chain reaction (RT-PCR) and serology in 13 consecutive patients with anti-FH antibody associated aHUS during the past year in New Delhi.
Results: We report 5 patients, 4-13 years old, who presented with a febrile illness without respiratory symptoms during the second pandemic wave. Of these, 3 patients presented with a relapse 25-85 months following the initial episode of aHUS. SARS-CoV-2 was detected by RT-PCR in 1 patient and by serology in 4 patients (median titer 47.1 cut-off index). Patients had high titers of anti-FH antibodies (median 2,300 AU/ml). Genetic studies, done in 3 of the 5 patients, showed homozygous CFHR1 deletion without other significant genetic abnormalities. Specific management comprised plasma exchanges and oral prednisolone, combined with either cyclophosphamide or mycophenolate mofetil. At median follow-up of 3.3 months, the estimated glomerular filtration rate in 4 patients ranged from 62 to 110 ml/min/1.73 m 2 ; one patient was dialysis-dependent.
Conclusion: Increased vigilance is required during the pandemic, especially in patients with anti-FH associated aHUS, who might relapse despite quiescent disease for a prolonged period. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keywords: Alternative complement pathway; Complement factor H related protein; Coronavirus 19; Factor H; Thrombotic microangiopathy.
【저자키워드】 Factor H, Alternative complement pathway, Complement factor H related protein, Coronavirus 19, Thrombotic microangiopathy., 【초록키워드】 SARS-CoV-2, pandemic, Pathogenesis, serology, antibody, SARS-COV-2 infection, Genetic, complement, RT-PCR, dialysis, polymerase chain reaction, Reverse transcriptase polymerase chain reaction, management, Patient, plasma, Follow-up, respiratory, information, disease, patients, plasma exchanges, Alternative complement pathway, glomerular filtration rate, thrombotic microangiopathy, Atypical, Trigger, respiratory symptoms, mycophenolate, autoantibody, Prednisolone, Cyclophosphamide, reverse transcriptase, Chain Reaction, filtration rate, episode of, mycophenolate mofetil, hemolytic uremic syndrome, Factor, estimated glomerular filtration rate, Abstract, one patient, Abnormalities, respiratory symptom, cut-off, Specific, transcriptase, Genetic studies, homozygous, CFHR1, febrile illness, uremic syndrome, median titer, polymerase chain, initial, required, screened, median, triggered, Increased, New, ranged, consecutive patient, 【제목키워드】 antibody,